Evidence map›Paper›PMID 40280973›Full record

ArticleScientific reports2025

Preparation of gold nanoparticles decorated UiO-66-NH

Leila Mohammadi, Mohammadreza Vaezi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Ni-Modified Defect-Engineered NHNanomaterials (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leila MohammadiDepartment of Nano Technology and Advanced Materials, Materials and Energy Research Center, Karaj, Iran. l.mohammadi3790@gmail.com.ORCID http://orcid.org/0000-0001-5741-1503
Mohammadreza VaeziDepartment of Nano Technology and Advanced Materials, Materials and Energy Research Center, Karaj, Iran. m_r_vaezi@merc.ac.ir.ORCID http://orcid.org/0000-0002-6238-9678

Funding

MERC 9911940
6 · The paper itself

Abstract

This study presents a new, highly effective, and reusable catalyst: UiO-66-NH

Identifiers

PMID40280973
PMCPMC12032121

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.